Tumor Marker Diagnostic Technologies and Their Potential Market Applications

Venture Planning Group (VPG), February 2012, Pages: 110

This 110-page report provides:

- Assessments and potential applications of monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry and biosensors or tumor marker diagnostic testing.
- Review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics spectroscopy.

Key topics covered include:

- Monoclonal and Polyclonal Antibodies
- Immunoassays
- Molecular Diagnostics
- Chromosome Analysis
- Artificial Intelligence
- Flow Cytometry
- Two Dimensional Gel Electrophoresis (2-DGE)
- Biosensors
- Competing/Complementing Technologies

1. Monoclonal and Polyclonal Antibodies

2. Immunoassays
a. Technological Principle
b. Radioimmunoassay (RIA)
c. Enzyme Immunoassays (EIA)
- Overview
- ELISA
- Immunofiltration
- Particle-Membrane Capture Immunoassay
- Enzyme Amplification
d. Fluorescent Immunoassays
e. Luminescence
- Chemiluminescence
- Bioluminescence
f. Latex Agglutination
g. Immunoprecipitation
H. Affinity Chromatographu
e. Liposome Flow-Injection Immunoassay

3. Molecular Diagnostics
a. Technology Overview
b. Amplification Methods
- PCR
- DAP-PCR
- Immuno-PCR
- QC-PCR
- CAR
- DNA
- HPA
- LCR
- NASBA
- QBR
- SDA
- 3 SR, and others

4. Chromosome Analysis
a. Chronic Myelogenous Leukemia (CML)
b. Acute Myeloid Leukemia (AML)
c. Acute Lymphoblastic Leukemia (ALL)
d. Malignant Lymphomas
Lymphoid Malignancies
e. Chronic Lymphocytic Leukemia (CLL)
f. Solid Cancers
g. Chromosomal Translocation and Oncogenes

5. Artificial Intelligence

6. Flow Cytometry

7. Two Dimensional Gel Electrophoresis (2-DGE)

8. Biosensors

9. Competing/Complementing Technologies
a. CT
b. MRI
c. NMR
d. PET
e. Photonics Spectroscopy

Customers who bought this item also bought

• Emerging Clinical Chemistry And Immunodiagnostic Technologies
• Therapeutic Drug Monitoring - Technologies, Markets, and Companies
• Future Clinical Chemistry Market: US, Europe, Japan
• Personalized Medicine - Scientific and Commercial Aspects
• The 2011 Japanese Molecular Diagnostics Market
• The 2011 US Molecular Diagnostics Market
• Future Coagulation Testing Market: Growth Opportunities and Business Expansion Strategies
• Leukemia Therapeutics Market (2010-2020) (Acute/Chronic lymphocytic leukemia & Acute/Chronic myeloid leukemia) Pipeline forecast & Market forecast in G8 countries
• Biopharmaceutical Expression Systems and Genetic Engineering Technology
• The 2011 Molecular Diagnostics Market: DNA Probes and Biochips -- New Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers